{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:29:50Z","timestamp":1792056590719,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ymgme.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:17:17Z","timestamp":1661422637000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): A systematic review"],"prefix":"10.1016","volume":"137","author":[{"given":"Aseel","family":"Bin Sawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jackimiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Trucillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Uyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ymgme.2022.08.005_bb0005","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/15476286.2018.1475178","article-title":"Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency","volume":"15","author":"Asrani","year":"2018","journal-title":"RNA Biol."},{"issue":"12","key":"10.1016\/j.ymgme.2022.08.005_bb0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00109-015-1354-3","article-title":"Arginase-1 deficiency","volume":"93","author":"Sin","year":"2015","journal-title":"J. Mol. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2022.08.005_bb0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.08.005_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1023\/A:1005313809037","article-title":"The human arginases and arginase deficiency","volume":"21","author":"Iyer","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0025","article-title":"Arginase deficiency","author":"Sun","year":"2020","journal-title":"GeneReviews\u00ae."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.08.005_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ymgme.2019.07.009","article-title":"Perspectives on urea cycle disorder management: results of a clinician survey","volume":"128","author":"Enns","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0035","series-title":"Arginase Deficiency","author":"Morales","year":"2020"},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-022-02226-8","article-title":"Arginase 1 deficiency: using genetic databases as a tool to establish global prevalence","volume":"17","author":"Catsburg","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.08.005_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2022.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00726-015-2032-z","article-title":"Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature","volume":"47","author":"Schlune","year":"2015","journal-title":"Amino Acids"},{"issue":"7","key":"10.1016\/j.ymgme.2022.08.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009880","article-title":"Argininemia as a cause of severe chronic stunting and partial growth hormone deficiency (PGHD): a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ymgme.2022.08.005_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-016-9928-y","article-title":"Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency","volume":"39","author":"Huemer","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.08.005_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005374027693","article-title":"Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan","volume":"21","author":"Uchino","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2022.08.005_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/humu.23545","article-title":"Mutations and common variants in the human arginase 1 (ARG1) gene: impact on patients, diagnostics, and protein structure considerations","volume":"39","author":"Diez-Fernandez","year":"2018","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.ymgme.2022.08.005_bb0075","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.3928\/19382359-20180426-01","article-title":"Updates in newborn screening","volume":"47","author":"Rajabi","year":"2018","journal-title":"Pediatr. Ann."},{"issue":"3","key":"10.1016\/j.ymgme.2022.08.005_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-67144-4_19","article-title":"Newborn screening: beyond the spot","volume":"1031","author":"Urv","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2022.08.005_bb0090","first-page":"1","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0095","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"issue":"7","key":"10.1016\/j.ymgme.2022.08.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0105","series-title":"Meta-Analyses of Randomized Controlled Clinical Trials to Evaluate the Safety of Human Drugs or Biological Products","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.ymgme.2022.08.005_bb0110","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.ymgme.2022.08.005_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12887-018-1090-2","article-title":"Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.08.005_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2014.07.018","article-title":"Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI\/MS\/MS): an 8 year journey from pilot to current program","volume":"113","author":"Lim","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.ymgme.2022.08.005_bb0130","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/s41436-019-0442-0","article-title":"Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders","volume":"21","author":"Burrage","year":"2019","journal-title":"Genet. Med."},{"issue":"4\u20135","key":"10.1016\/j.ymgme.2022.08.005_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clinbiochem.2009.12.004","article-title":"Clinical and biochemical characteristics of patients with urea cycle disorders in a developing country","volume":"43","author":"Ibarra-Gonzalez","year":"2010","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.ymgme.2022.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11011-018-0259-6","article-title":"Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment","volume":"33","author":"Kido","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13023-016-0513-0","article-title":"Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study","volume":"11","author":"Husson","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajmg.1320550220","article-title":"Prenatal diagnosis of the urea cycle diseases: a survey of the European cases","volume":"55","author":"Kamoun","year":"1995","journal-title":"Am. J. Med. Genet."},{"issue":"10","key":"10.1016\/j.ymgme.2022.08.005_bb0155","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1651-2227.2008.00923.x","article-title":"Hereditary urea cycle diseases in Finland","volume":"97","author":"Keskinen","year":"2008","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","article-title":"Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland","volume":"12","author":"Nettesheim","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-016-0004-4","article-title":"Long-term outcome of expanded newborn screening at Boston children\u2019s hospital: benefits and challenges in defining true disease","volume":"40","author":"Landau","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2018.04.006","article-title":"Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening","volume":"124","author":"Merritt","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ymgme.2013.09.003","article-title":"Dietary management of urea cycle disorders: European practice","volume":"110","author":"Adam","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01846026","article-title":"Diagnostic value of orotic acid excretion in heritable disorders of the urea cycle and in hyperammonemia due to organic acidurias","volume":"134","author":"Bachmann","year":"1980","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2022.08.005_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/pd.884","article-title":"Genetic approach to prenatal diagnosis in urea cycle defects","volume":"24","author":"H\u00e4berle","year":"2004","journal-title":"Prenat. Diagn."},{"issue":"5","key":"10.1016\/j.ymgme.2022.08.005_bb0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10545-016-9938-9","article-title":"Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders","volume":"39","author":"Posset","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-013-9624-0","article-title":"Cross-sectional observational study of 208 patients with non-classical urea cycle disorders","volume":"37","author":"R\u00fcegger","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13023-018-0908-1","article-title":"Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing","volume":"13","author":"Bijarnia-Mahay","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21101\/cejph.a5441","article-title":"Epidemiology of rare diseases detected by newborn screening in the Czech Republic","volume":"27","author":"David","year":"2019","journal-title":"Cent. Eur. J. Public Health"},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0210","first-page":"876","article-title":"A simple screening test for arginase deficiency (hyperargininemia)","volume":"89","author":"Naylor","year":"1977","journal-title":"J. Lab. Clin. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.70.4.526","article-title":"A neonatal screening test for argininosuccinic acid lyase deficiency and other urea cycle disorders","volume":"70","author":"Talbot","year":"1982","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2022.08.005_bb0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pediatrneurol.2012.03.016","article-title":"Clinical features and neurologic progression of hyperargininemia","volume":"46","author":"Carvalho","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2022.08.005_bb0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1203\/00006450-199003000-00020","article-title":"Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy","volume":"27","author":"Marescau","year":"1990","journal-title":"Pediatr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.08.005_bb0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1023\/A:1005317909946","article-title":"Liver transplantation for the treatment of urea cycle disorders","volume":"21","author":"Whitington","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2022.08.005_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1013960712516","article-title":"Liver transplantation in a case of argininaemia","volume":"24","author":"Santos Silva","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0240","first-page":"25","article-title":"Liver transplantation prevents progressive neurological impairment in argininemia","volume":"11","author":"Silva","year":"2013","journal-title":"JIMD Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0245","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10545-016-9942-0","article-title":"Improving long term outcomes in urea cycle disorders-report from the urea cycle disorders consortium","volume":"39","author":"Waisbren","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.08.005_bb0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2011.06.025","article-title":"Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?","volume":"104","author":"Jain-Ghai","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2022.08.005_bb0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1620\/tjem.142.239","article-title":"A successful trial of enzyme replacement therapy in a case of argininemia","volume":"142","author":"Sakiyama","year":"1984","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0260","article-title":"Physical, cognitive, and social status of patients with urea cycle disorders in Japan","volume":"27","author":"Kido","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0265","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jimd.12384","article-title":"Long-term outcome of urea cycle disorders: report from a nationwide study in Japan","volume":"44","author":"Kido","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0270","article-title":"Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia","volume":"27","author":"Huang","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00230212","article-title":"Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme","volume":"91","author":"Grody","year":"1993","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2022.08.005_bb0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/088307389701200502","article-title":"Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review","volume":"12","author":"Prasad","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0285","article-title":"Current status of surviving patients with arginase 1 deficiency in Japan","volume":"29","author":"Kido","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0290","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.spen.2017.03.016","article-title":"\u201cCerebral palsy\u201d in a patient with arginase deficiency","volume":"26","author":"Jichlinski","year":"2018","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.genom.3.022502.103213","article-title":"The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism","volume":"3","author":"Chace","year":"2002","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0146-0005(99)80050-0","article-title":"Application of electrospray tandem mass spectrometry to neonatal screening","volume":"23","author":"Rashed","year":"1999","journal-title":"Semin. Perinatol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41439-021-00139-9","article-title":"Novel ARG1 variants identified in a patient with arginase 1 deficiency","volume":"8","author":"Yokoi","year":"2021","journal-title":"Hum. Genome Var."},{"issue":"1","key":"10.1016\/j.ymgme.2022.08.005_bb0310","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/13696998.2022.2089517","article-title":"Health care resource utilization in the management of patients with arginase 1 deficiency in the US: a retrospective, observational, claims database study","volume":"25","author":"Bin Sawad","year":"2022","journal-title":"J. Med. Econ."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0315","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jimd.12343","article-title":"Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency","volume":"44","author":"Diaz","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2022.08.005_bb0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2022.01.035","article-title":"Pegzilarginase in arginase 1 deficiency: results of the peace pivotal phase 3 clinical trial","volume":"135","author":"Enns","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0920-1211(91)90081-P","article-title":"Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture","volume":"8","author":"De Deyn","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymgme.2022.08.005_bb0330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4020-6486-9_9","article-title":"Pre-symptomatic treatment of creatine biosynthesis defects","volume":"46","author":"Schulze","year":"2007","journal-title":"Subcell. Biochem."},{"issue":"9","key":"10.1016\/j.ymgme.2022.08.005_bb0335","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s11064-008-9636-6","article-title":"Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats","volume":"33","author":"Zugno","year":"2008","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2022.08.005_bb0340","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2007.09.016","article-title":"Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia","volume":"93","author":"Deignan","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.08.005_bb0345","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ymgme.2010.01.012","article-title":"Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia","volume":"100","author":"Deignan","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2022.08.005_bb0350","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/dmcn.12488","article-title":"Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring","volume":"56","author":"Amayreh","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"issue":"17","key":"10.1016\/j.ymgme.2022.08.005_bb0355","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130260","article-title":"Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222003924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222003924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:29Z","timestamp":1761090869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222003924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":71,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1096719222003924"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.08.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, methods of diagnosis, and clinical management of patients with arginase 1 deficiency (ARG1-D): A systematic review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}